Literature DB >> 15211397

[AWMF-guideline: disorders related to cannabis].

U Bonnet1, K Harries-Hedder, F M Leweke, U Schneider, P Tossmann.   

Abstract

Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cannabis-related disorders is introduced.

Mesh:

Year:  2004        PMID: 15211397     DOI: 10.1055/s-2004-818388

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  3 in total

Review 1.  Risks associated with the non-medicinal use of cannabis.

Authors:  Eva Hoch; Udo Bonnet; Rainer Thomasius; Florian Ganzer; Ursula Havemann-Reinecke; Ulrich W Preuss
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

Review 2.  Evidence-based Treatment Options in Cannabis Dependency.

Authors:  Lisa Walther; Andreas Gantner; Andreas Heinz; Tomislav Majić
Journal:  Dtsch Arztebl Int       Date:  2016-09-30       Impact factor: 5.594

3.  [Use of an outpatient treatment center for cannabis abuse].

Authors:  F Hölscher; U Bonnet; N Scherbaum
Journal:  Nervenarzt       Date:  2008-05       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.